BlackRock Advisors’s Assembly Biosciences ASMB Stock Holding History

BlackRock Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$33K	Hold	225	–	–	﹤0.01%	3346
2016 Q3	$19K	Hold	225	–	–	﹤0.01%	3462
2016 Q2	$15K	Sell	225 -309	-58%	-$20.3K	﹤0.01%	3502
2016 Q1	$32K	Hold	534	–	–	﹤0.01%	3303
2015 Q4	$48K	Sell	534 -268	-33%	-$29.2K	﹤0.01%	3203
2015 Q3	$92K	Buy	802 +128	+19%	+$22.5K	﹤0.01%	3132
2015 Q2	$156K	Buy	+674	New	+$130K	﹤0.01%	2941
2014 Q3	–	Sell	-115	Closed	-$9K	–	3676
2014 Q2	$9K	Hold	115	–	–	﹤0.01%	3585
2014 Q1	$9K	Hold	115	–	–	﹤0.01%	3551
2013 Q4	$26K	Buy	115 +30	+35%	+$5.46K	﹤0.01%	3344
2013 Q3	$15K	Sell	85 -19	-18%	-$2.91K	﹤0.01%	3369
2013 Q2	$15K	Buy	+104	New	+$16.3K	﹤0.01%	3321

Other funds holding ASMB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock Advisors's ASMB Position: Q4 2016 in Review

BlackRock Advisors held its Assembly Biosciences (ASMB) position steady in Q4 2016 at 225 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

BlackRock Advisors first reported a position in ASMB in Q2 2013 and has held it in 12 quarters since. The position peaked at $156K in Q2 2015. 36 funds tracked by Wall St. Rank hold ASMB as of Q4 2016.

BlackRock Advisors held 225 shares of Assembly Biosciences worth $33K as of Q4 2016.
BlackRock Advisors left its Assembly Biosciences share count unchanged in Q4 2016.
Assembly Biosciences made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3346 holding.
BlackRock Advisors first reported a position in Assembly Biosciences in Q2 2013 and has held it in 12 quarters since.
BlackRock Advisors's Assembly Biosciences position peaked at $156K in Q2 2015.
36 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.